185 related articles for article (PubMed ID: 21933635)
1. Fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging of uterine leiomyosarcomas: 2 cases report.
Zhang HJ; Zhan FH; Li YJ; Sun HR; Bai RJ; Gao S
Chin Med J (Engl); 2011 Jul; 124(14):2237-40. PubMed ID: 21933635
[TBL] [Abstract][Full Text] [Related]
2. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
[TBL] [Abstract][Full Text] [Related]
4. Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI.
Kitajima K; Murakami K; Yamasaki E; Kaji Y; Sugimura K
Ann Nucl Med; 2008 Jul; 22(6):505-12. PubMed ID: 18670857
[TBL] [Abstract][Full Text] [Related]
5. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
Ohno Y; Koyama H; Takenaka D; Nogami M; Maniwa Y; Nishimura Y; Ohbayashi C; Sugimura K
J Magn Reson Imaging; 2008 Jun; 27(6):1284-95. PubMed ID: 18504748
[TBL] [Abstract][Full Text] [Related]
6. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
Wu ZJ; Zhang YX; Wei H; Jia Q
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544
[TBL] [Abstract][Full Text] [Related]
7. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
8. Prolapsed endometrial cancer: FDG PET/CT findings.
Kaneta T; Hakamatsuka T; Yamada T; Sato A; Higano S; Fukuda H; Takahashi S; Yamada S
Clin Nucl Med; 2006 Mar; 31(3):180. PubMed ID: 16495748
[No Abstract] [Full Text] [Related]
9. In-line (18)F-fluorodeoxyglucose positron emission tomography with computed tomography (PET/CT) in patients with carcinoma of the sinus/nasal area and orbit.
Wild D; Eyrich GK; Ciernik IF; Stoeckli SJ; Schuknecht B; Goerres GW
J Craniomaxillofac Surg; 2006 Jan; 34(1):9-16. PubMed ID: 16343913
[TBL] [Abstract][Full Text] [Related]
10. Marginal zone lymphoma involving subcutaneous fat: appearance by FDG-PET/CT, MRI, and contrast-enhanced CT imaging.
Chong EA; Torigian DA; Mato AR; Downs LH; Schuster SJ
Clin Nucl Med; 2008 Oct; 33(10):692-3. PubMed ID: 18806570
[No Abstract] [Full Text] [Related]
11. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
[TBL] [Abstract][Full Text] [Related]
12. Determination of age-related changes in structure and function of skin, adipose tissue, and skeletal muscle with computed tomography, magnetic resonance imaging, and positron emission tomography.
Wehrli NE; Bural G; Houseni M; Alkhawaldeh K; Alavi A; Torigian DA
Semin Nucl Med; 2007 May; 37(3):195-205. PubMed ID: 17418152
[TBL] [Abstract][Full Text] [Related]
13. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma.
Pfannenberg C; Aschoff P; Schanz S; Eschmann SM; Plathow C; Eigentler TK; Garbe C; Brechtel K; Vonthein R; Bares R; Claussen CD; Schlemmer HP
Eur J Cancer; 2007 Feb; 43(3):557-64. PubMed ID: 17224266
[TBL] [Abstract][Full Text] [Related]
14. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
Du Y; Cullum I; Illidge TM; Ell PJ
J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography with (18)F-fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging.
Umesaki N; Tanaka T; Miyama M; Kawamura N; Ogita S; Kawabe J; Okamura T; Koyama K; Ochi H
Gynecol Oncol; 2001 Mar; 80(3):372-7. PubMed ID: 11263934
[TBL] [Abstract][Full Text] [Related]
16. [MRI of uterine leiomyosarcoma. Apropos of 2 cases].
Mélia P; Maestro C; Bruneton JN; Gasperoni A; Peyrottes I; Teissier E; Marcy PY
J Radiol; 1995 Jan; 76(1):69-72. PubMed ID: 7861374
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography using 2-[(18)F] fluoro-2-deoxy-D-glucose in the diagnosis of uterine leiomyosarcoma: a case report.
Umesaki N; Tanaka T; Miyama M; Ogita S; Kawabe J; Okamura T; Koyama K; Ochi H
Clin Imaging; 2001; 25(3):203-5. PubMed ID: 11679229
[TBL] [Abstract][Full Text] [Related]
18. Intense F-18 FDG accumulation in idiopathic tumoral calcinosis.
Okuyama C; Kubota T; Matsushima S; Ushijima Y; Nishimura T
Clin Nucl Med; 2009 Apr; 34(4):230-2. PubMed ID: 19300054
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomographic-computed tomographic imaging of a uterine sarcoma.
Cher S; Lay Ergun E
Clin Nucl Med; 2003 May; 28(5):443-4. PubMed ID: 12702956
[No Abstract] [Full Text] [Related]
20. Uterine leiomyosarcoma--magnetic resonance imaging.
Janus C; White M; Dottino P; Brodman M; Goodman H
Gynecol Oncol; 1989 Jan; 32(1):79-81. PubMed ID: 2909452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]